Immutep said IMP761 was found safe in initial data from a Phase 1 trial, with no treatment-related adverse events reported.

Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, ...

Columnist Ahna Crum knows what MS has taken from her, but she also recognizes the significant gifts it's granted over the ...

Columnist Desiree Lama has been living with MS for several years, yet she still appreciatea the advice and advocacy of her ...

Tolebrutinib, expected to soon be submitted for U.S. approval for nonrelapsing SPMS, was granted the FDA's breakthrough ...

About four in five adults with long-term stable MS who stopped first-line treatment with a DMT showed signs of disease ...

A high genetic risk for MS, along with exposure to tobacco or other environmental factors, can affect early brain development ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Columnist Ben Hofmeister recognizes how he doesn't want to lose control, even as he's learning to part with it willingly.

Two studies linked a type of lesions with chronic inflammation, paramagnetic rim lesions, with worse MS disability ...

Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...